Authors Posts by Seema Singh

Seema Singh

Seema Singh
15 POSTS 0 COMMENTS
Writer and Editor

Curadev’s drug discovery slot machine

 A certain starkness marks the entrance to Curadev Pharma Private Limited. Freshly painted, the walls are bare; the reception desk is unmanned. The company does mostly science and doesn’t need a front desk; not yet. Ask them about the emptiness and co-founders Arjun Surya and Manish Tandon look at the ceiling and wistfully discuss how the AstraZeneca headquarters in...

Portea’s long (and short) cut to home care

Smack in the middle of the national narrative that India is one of the youngest countries, in 2013 Portea shined a light on elderly care. In absolute terms, the 100 million elderly population is only going to swell. While a few others existed in this space, Portea came blazing a trail as far as scale was concerned in providing “hospital-like...

Meet India’s Judge Dredd of Dengue

Everything’s warmer this winter in Delhi, even a dengue discussion. For years Navin Khanna has studied dengue and other infections with a quiet purposefulness. As he settles into the cane chair, at the faculty lounge and boots up his MacBook, the academic aloofness of the place recedes. In the 26 years that Khanna has been at the International Centre...

Spotting health in India’s healthcare

The year is coming to an end. As we take stock, we are delighted to note what we've managed to do in three short months. And are grateful to have found you as readers. Thank you.Now we slip into a short break. Starting today, our writers will pick a theme each day, explaining some of the stories we've written...

MedGenome: Deciphering disease and consumer market

If there is one company in India using the brute force of computing and high-speed sequencing to offer services in genetics, it is MedGenome. So important is the sequencing technology that owning a high-end machine becomes a news release. As it happened in October, after it bought Illumina’s Hiseq X Ten platform. If not in the consumer (or clinical) market,...

One Rocket, Many Satellites: Isro’s final push to India’s commercial space lift-off

At the end of a public event in Mysore, three young engineers walked up to the chief guest AS Kiran Kumar, chairman of Isro. Rohan Ganapathy and his team had built a prototype of a new propulsion system for satellites and wanted to draw the chairman’s attention towards it. Which they did. A few days later, in late 2015,...

Mitra Biotech’s hunt for mutations and moolah

Even though cancer for every patient is unique, the disease is largely treated with one-size-fits-all drugs. Result: poor response to drugs and horrible side-effects, which are often worse than the disease. In this prevalent practice, Mitra Biotech landed with a proprietary algorithmic platform, CANScript, which personalises cancer care. It's a product that took nearly six years to make the...

The mounting NPAs of India’s stem cell banks

It wasn’t a subject Deepak Ghaisas understood at all. But he was trying, even before he fully exited i-flex, a financial product company that he had incubated at Citi Group, which was acquired by Oracle in 2005. When Ghaisas did exit, in 2008, he was convinced he wanted to do something “different at age 50”. A year later, that...

To Moon and Mars, again

Many theories and metaphors exist on how the Moon got its rugged, groovy looks. Last week, one of the long-running lunar programmes of Nasa revealed how one of the biggest and the youngest crater—there are thousands on the Moon—was formed. The 3.8 billion-year-old Orientale has withstood severe fracturing, melting, virtually all brutal natural phenomena, upon its crust to become...

The Great Pharma U-Turn

In a quiet disclosure to analysts last month, Lupin said it had added nearly a 1000 people to its field force, taking the total count to 5500. Sources say one more large company is going to make a similar hiring announcement in the next quarter. But wait. Did we not get to understand, just a few years ago, that most Indian pharma companies were cutting down medical representative hiring and “adopting technology to minimize the cost of marketing and promotion”? Whatever happened to that?

Featured stories

Send this to friend